Held · Bookmarked
0 · 0
portfolios · users
Avg position size
—
of holders' portfolios
13F filers
2
institutions
Market cap
$10.2B
59M shares
52-week range
$140.08 – $246.33
35% from low
Sector
SERVICES-GENERAL MEDICAL & SURGICAL HOSPITALS, NEC
Exchange
NYSE
CS
P/S (TTM)
0.6
EV / FCF (TTM)
19.0
Universal Health Services Inc offers healthcare services through its behavioral health centers, acute care hospitals, and related outpatient facilities. As of late 2025, the company operated 346 inpatient behavioral health centers, 29 acute care hospitals, and many supportive outpatient facilities. Its operations are concentrated in the U.S, particularly in Nevada (21% of 2025 operating profits), Texas (19%), and California (13%), although it does have some exposure to the UK behavioral health market (6% of 2025 sales) too. While its acute care services account for over 55% of revenue, the behavioral health centers sport higher margins and account for over 55% of pretax profits.
www.uhs.comNo one on the platform currently holds UHS.
| Institution | Shares | Reported |
|---|---|---|
| Bridgewater Associatesas of 2026-03-31 | 136,368 | $24.4M |
| Renaissance Technologiesas of 2025-03-31 | 69,900 | $13.1M |
| Ex-date | Per share | Pay date |
|---|---|---|
| 2026-09-01 | $0.2000 | 2026-09-15 |
| 2026-06-08 | $0.2000 | 2026-06-18 |
| 2026-03-02 | $0.2000 | 2026-03-16 |
| 2025-12-01 | $0.2000 | 2025-12-15 |
| 2025-09-02 | $0.2000 | 2025-09-16 |
| 2025-06-02 | $0.2000 | 2025-06-16 |
| 2025-03-03 | $0.2000 | 2025-03-17 |
| 2024-12-03 | $0.2000 | 2024-12-17 |
| 2024-09-03 | $0.2000 | 2024-09-17 |
| 2024-06-03 | $0.2000 | 2024-06-17 |
No one on the platform has traded UHS yet.
| 2024-02-29 | $0.2000 | 2024-03-15 |
| 2023-11-30 | $0.2000 | 2023-12-15 |
| Execution date | Ratio |
|---|---|
| 2009-12-16 | 2-for-1 |
Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.
Consensus does not cover every selected forecast year. Later assumptions are extrapolated from available analyst estimates.
| Metric | Historical average | My assumptions | ||||
|---|---|---|---|---|---|---|
| 1 year | 5 years | 10 years | Low | Mid | High | |
| ROIC % | 12.0% | 9.6% | 9.8% | — | — | — |
| Rev. Growth % | 9.7% | 8.5% | ||||
| Profit Margin % | 8.6% | 6.7% | 7.1% | |||
| Free Cash Flow Margin % | 4.9% | 3.6% | 5.0% | |||
| Exit P/E | — | — | — | |||
| Exit P/FCF | — | — | — | |||
| Desired Annual Return % | — | — | — | |||
At today's price, your expected annual return is -1.2% on the P/E track.
At today's price, your expected annual return is +4.3% on the P/E track.
At today's price, your expected annual return is +8.5% on the P/E track.
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2026 | $18.6B | +7.1% | $22.53 | $22.03–$23.06 | 7.9× | 12 |
| 2027 | $19.5B | +4.7% | $24.04 | $23.08–$25.64 | 7.4× | 12 |
| 2028 | $20.4B | +4.5% | $26.58 | $24.32–$28.33 | 6.7× | 9 |
| 2029 | $21.2B | +4.2% | $25.65 | $24.84–$26.47 | 6.9× | 3 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
Beat consensus in 7 of the last 8 reported quarters
| Reported | Est. EPS | Actual | Surprise |
|---|---|---|---|
| 2026-07-27 | $5.94 | $5.98 | +0.7% |
| 2026-04-27 | $5.41 | $5.62 | +3.9% |
| 2026-02-25 | $5.92 | $5.88 | -0.7% |
| 2025-10-27 | $4.66 | $5.69 | +22.1% |
| 2025-07-28 | $4.92 | $5.35 | +8.7% |
| 2025-04-28 | $4.35 | $4.84 | +11.3% |
| 2025-02-26 | $4.21 | $4.92 | +16.9% |
| 2024-10-24 | $3.65 |
| $3.71 |
| +1.6% |
| +1.03% |
| $416M |
| — |
| DVADaVita Inc. | $189.32 | +4.28% | $12.2B | — |
| EHCEncompass Health Corporation | $122.53 | +0.67% | $12.2B | — |
Source: Financial Modeling Prep · peers by sector/industry
The most recent New High signal on $UHS triggered on 2026-08-26. The expected return for the selected horizon is +6.01% with a historical profit probability of +64.08%. Learn more: https://axlfi.com/factor-analysis?symbol=UHS&factor=new_high&timeframe=daily
View on StockTwits ↗
$GOGO This is a successful company hit with the two headwinds of transitioning from legacy ATG and FAA delays. Aside from that, fundamentals are strong. Just like I predicted $UHS $BFAM and $PTRN would all rebound (and did!), so too will GOGO. Hard to lose on deep value plays that are executing their plan consistently. With that said, it can be tough to buy into fear! But buying into fear is where I make money.
View on StockTwits ↗
$DCGO Woohoo - Elvis has NOT left the building yet!! "$UHS is open to additional acquisitions in the virtual and behavioral health spaces if it feels they’ll drive growth, according to Miller. The system already works with a number of other companies like Talkspace, and if one decides to sell, UHS would be a natural acquirer, the CEO said — though UHS is particularly interested in targets with unique advantages, like first-rate technology."
View on StockTwits ↗$DCGO "$UHS is open to additional acquisitions in the virtual and behavioral health spaces if it feels they’ll drive growth, according to Miller. The system already works with a number of other companies like Talkspace, and if one decides to sell, UHS would be a natural acquirer, the CEO said — though UHS is particularly interested in targets with unique advantages, like first-rate technology."
View on StockTwits ↗
$TALK wtf….my shares just disappeared….are we supposed to get $UHS ?
View on StockTwits ↗
$UHS is this the company that runs the Provo canyon School that basically tortured Paris Hilton and now got exposed by reckless Ben? I wonder what the stock is going to do Monday.
View on StockTwits ↗
S&P Global Ratings revised its outlook on Universal Health Services to positive from stable and affirmed its ‘BB+’ issuer credit rating. It also assigned a ‘BBB-’ issue rating and ‘2’ recovery rating to the company’s proposed senior notes, implying substantial 70%-90% recovery in a default. The positive outlook reflects potential for an upgrade if UHS maintains leverage at 2.0x-3.0x and healthcare policy risks remain contained. Proceeds from the notes will refinance $700 million of debt due in September 2026 and fund part of its $835 million acquisition of Talkspace, with the remaining purchase price financed through a recently issued $400 million delayed-draw term loan. S&P expects UHS revenue growth to slow from 9.7% in 2025, forecasting 7%-7.5% growth in 2026 and 6%-6.5% in 2027. Adjusted EBITDA margins are expected to fall about 60 bps to 15.5% in 2026, while adjusted free operating cash flow to debt should improve to 17.7% from 16.7%. $UHS
View on StockTwits ↗
$TALK The merger with $UHS is happening and institutions are positioning. https://www.marketbeat.com/instant-alerts/filing-dimensional-fund-advisors-lp-raises-stake-in-talkspace-inc-talk-2026-08-09/ LT
View on StockTwits ↗
$UHS Analysis: https://onlytradersfans.com/threads/analisis-uhs.12933/
View on StockTwits ↗
$UHS Hospital operators face acute reimbursement pressure from Medicaid supplemental payment program changes and rising uninsured patient volumes following ACA subsidy expiration, forcing earnings guidance reductions and margin compression. Learn more: https://axlfi.com/themes/454
View on StockTwits ↗Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.
Click to see transaction details on SEC.gov. Form 4s cover trades by officers, directors, and 10%+ owners, due within 2 business days of the trade.